A Window into the Heterogeneity of Human Cerebrospinal Fluid Aβ Peptides
Open Access
- 1 January 2011
- journal article
- review article
- Published by Wiley in BioMed Research International
- Vol. 2011 (1) , 697036
Abstract
The initiating event in Alzheimer′s disease (AD) is an imbalance in the production and clearance of amyloid beta (Aβ) peptides leading to the formation of neurotoxic brain Aβ assemblies. Cerebrospinal Fluid (CSF), which is a continuum of the brain, is an obvious source of markers reflecting central neuropathologic features of brain diseases. In this review, we provide an overview and update on our current understanding of the pathobiology of human CSF Aβ peptides. Specifically, we focused our attention on the heterogeneity of the CSF Aβ world discussing (1) basic research studies and what has been translated to clinical practice, (2) monomers and other soluble circulating Aβ assemblies, and (3) communication modes for Aβ peptides and their microenvironment targets. Finally, we suggest that Aβ peptides as well as other key signals in the central nervous system (CNS), mainly involved in learning and hence plasticity, may have a double‐edged sword action on neuron survival and function.Keywords
This publication has 112 references indexed in Scilit:
- RETRACTED: Cognitive effects of cell-derived and synthetically derived Aβ oligomersNeurobiology of Aging, 2011
- Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer's diseaseNeurobiology of Aging, 2011
- Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s diseaseActa Neuropathologica, 2010
- Can Alzheimer disease be prevented by amyloid-β immunotherapy?Nature Reviews Neurology, 2010
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer DiseaseArchives of Neurology, 2009
- Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderlyAnnals of Neurology, 2009
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008
- Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrilsProceedings of the National Academy of Sciences, 2007
- Alzheimer's disease beta-amyloid peptides are released in association with exosomesProceedings of the National Academy of Sciences, 2006